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EXECUTIVE SUMMARY
The goal of the Innovative Prosecution Solutions for Combating Violent Crime 
and Illegal Opioids (IPS) grant is to reduce opioid-related deaths by fostering 
inter-agency collaboration to disrupt local opioid supply chains, educate the 
community about the dangers of opioid abuse and addiction, and provide support 
for individuals with opioid use disorder.
This report describes: 1) the history and 
current state of the opioid crisis in East Baton 
Rouge Parish; 2) the current and planned 
efforts of the IPS grant to respond to the 
crisis; and 3) recommendations for criminal 
justice practitioners regarding the opioid 
crisis in our community.
The rising prevalence of opioid-related is a 
significant issue in East Baton Rouge Parish, 
Louisiana. From 2014 to 2018:
• Opioid poisoning-related emergency 
department visits increased by 45%,
• Heroin poisoning-related emergency 
department visits increased by 30%, 
and
• Non-heroin opioid poisoning-related 
emergency department visits increased 
by 59%. 
As emergency department visits increased, 
so did overdose deaths in East Baton Rouge 
Parish:
• From 2018 to 2019, opioid overdose 
deaths increased by 29%. Opioid 
overdose deaths have consistently 
accounted for nearly all overdose 
deaths during this time frame.
• From January to June 2020, opioid 
overdose deaths increased by 113% 
compared to the same months of 2019.
Early attempts to address the opioid crisis 
were challenging due to a lack of trust 
and cooperation among governmental 
agencies and community members most 
affected by the opioid epidemic. Criminal 
justice practitioners (e.g., law enforcement, 
correctional officials, defense attorneys, 
prosecutors, court officials) have an important 
role in reducing opioid-related addiction,  
overdose deaths, and violence within East 
Baton Rouge Parish communities. Individuals 
with substance use disorder are often fearful 
of interacting with law enforcement due to 
the belief that they will be arrested for their 
addiction, decreasing the likelihood that 
these individuals will reach out for critical 
treatment. Therefore, public health officials 
can be reluctant to include criminal justice 
practitioners in opioid use disorder-related 
efforts, despite their ability to engage in 
meaningful, productive partnerships. 
For these perceptions to change, 
criminal justice practitioners must 
demonstrate a commitment to 
addiction and overdose prevention 
by forming vital partnerships and 
supporting their partners’ prevention 
efforts to address this epidemic.
By engaging in meaningful community 
partnerships, criminal justice practitioners can 
implement and support efforts to improve the 
lives of individuals with opioid use disorder 
and reduce opioid overdose deaths. The 
following recommendations were informed by 
empirical research related to criminal justice 
and public health interventions concerning 
opioid use disorder. This report further details 
each recommendation.
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RECOMMENDATIONS
FOR CRIMINAL JUSTICE PRACTITIONERS IN THE COMMUNITY
Strengthen 
community 
partnerships to expand 
access points
Partner with public health and community organizations 
to implement protocols which emphasize connecting 
individuals with substance use disorders to viable treatment 
programs and removing existing barriers to adequate 
treatment and recovery.
Expand 
prescription medication 
disposal programs
Engage in community partnerships to expand prescription 
medication disposal programs by permanently establishing 
secure disposal sites for unused and expired medication 
at law enforcement substations and other amenable 
community locations.
Expand 
community education 
efforts
Expand planned community education efforts, such as 
push cards and community forums, to include information 
about situation-specific support programs for survivors 
(e.g., pregnancy-based treatment, neonatal treatment, safe 
needle exchange sites).
Support 
the expansion of 
effective treatment and 
harm reduction efforts
Support harm reduction efforts, such as needle exchange 
programs, Take Home Naloxone programs for hospitals, 
fentanyl testing kits, as well as community-wide access to 
evidence-based treatments such as medication-assisted 
treatment (MAT) and peer-recovery programs. 
Publicize 
the Good 
Samaritan Laws
Partner with public health and community organizations to 
raise public awareness of the current Good Samaritan laws, 
including situational limitations for immunity.
Bolster 
prevention efforts
Develop cross sector partnerships to prevent the 
development of substance misuse among youth and other 
vulnerable populations through educational campaigns.
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Implement 
departmental protocols 
regarding possession 
and use
Develop departmental protocols that emphasize 
linking individuals to treatment and obtaining 
cooperation, which would enhance the ability 
to pursue those responsible for manufacturing, 
supplying, and distributing illegal narcotics in the 
community.
Continue to utilize 
federal law 
enforcement levers
Continue leveraging federal law enforcement 
partnerships to access the investigatory and 
prosecutorial resources available to East 
Baton Rouge Parish as a High Intensity Drug 
Trafficking Area (HIDTA) to pursue cases involving 
manufacturers, suppliers, and distributors.
Identify and monitor 
social networks using 
social media data
Use data scraping techniques and social network 
analysis to identify patterns of illicit drug sales 
occurring on public social media.
Develop 
a forensic certification-
based Collegiate 
Internship Program
Provide local college students with the necessary 
training to receive a uniform forensic analyst 
certification, as well as professional experience 
utilizing this training within a Crime Strategies Unit 
or local law enforcement agency.
Provide 
appropriate referrals to 
drug court
Refer potential participants to the District Attorney 
for the 19th JDC Drug Court treatment and 
diversion program.
Establish
a Prison Take Home 
Naloxone Program
Distribute naloxone upon release to individuals 
who have a history of substance use disorder, 
overdose, or charges pertaining to drug use, 
as well as provide training on proper naloxone 
administration, to reduce overdose deaths after 
release.
RECOMMENDATIONS
FOR CRIMINAL JUSTICE PRACTITIONERS IN THE FIELD
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Establish 
a Leave Behind 
Naloxone Program
Collaborate with public health and community 
organizations to establish a Leave Behind 
Naloxone Program. First responders should be 
prepared to leave naloxone with the survivor of 
an overdose or individuals in a position to assist 
the survivor, as well as provide training on proper 
naloxone administration.
Provide 
insight regarding 
overdose hotspots
Partner with public health officials to share relevant 
data about the location of overdoses and the 
concentration of hotspots to inform the deployment 
of resources (e.g., Louisiana State Opioid Response 
Medication-Assisted Treatment Mobile Unit) and 
prevention specialists.
Implement 
a Public Health and 
Safety Team (PHAST)
Partner with public health and community 
organizations to implement a Public Health and 
Safety Team (PHAST) responsible for conducting 
overdose fatality reviews.
RECOMMENDATIONS
FOR CRIMINAL JUSTICE PRACTITIONERS IN THE FIELD
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STATEMENT OF THE PROBLEM
The rising prevalence of opioid-related overdose deaths and opioid-related violence has 
become a significant issue in East Baton Rouge Parish, Louisiana. Early attempts to address the 
opioid crisis were a challenge for criminal justice practitioners. A lack of coordination among 
governmental agencies, along with a lack of trust and cooperation among community members 
most affected by the opioid epidemic, led to barriers in disrupting the illicit opioid drug market 
through the investigation and prosecution of opioid suppliers. Education about opioid addiction 
among law enforcement and community members was needed to foster an understanding that 
opioid overdoses are not victim-less crimes to be dismissed. 
To combat the opioid crisis, criminal justice practitioners recognized the need to use 
empirical, evidence-based interventions to interrupt the opioid drug market and reduce violent 
crime related to drug trafficking. The Innovative Prosecution Solutions for Combating Violent 
Crime and Illegal Opioids (IPS) grant, led by the District Attorney Hillar C. Moore of the 19th 
Judicial District, has proposed several interventions to reduce opioid-related deaths in East 
Baton Rouge Parish.
This document describes the history and current state of the opioid crisis in East Baton 
Rouge Parish, the current and planned efforts of the IPS grant to respond to the crisis, and 
further recommendations that the criminal justice community might implement or support to 
reduce opioid overdose deaths in our community.
Historical National Trends
Prescription Opioid Abuse
Opioid prescribing in the United States increased rapidly at the beginning of the 
21st century due to decades of aggressive marketing tactics employed by pharmaceutical 
corporations and the unproven yet widely-held assumptions in the medical community about 
the effectiveness and safety of long-term opioid treatment to treat acute and chronic pain.1, 
2, 3 From 1999 to 2008, opioid prescription sales in the United States increased by 400%,4 
consumption of hydrocodone increased by over 200%, and consumption of oxycodone 
increased by nearly 500%.3 
The Criminal Justice Response to the Opioid Crisis in East Baton Rouge Parish-August 2020 6
Because prescription opioids were easier to access, non-medical prescription opioid 
abuse sharply increased throughout the late 1990s and early 2000s, peaking in 2002 with 2.7 
million new non-medical users.3 As prescriptions of opioids increased, so did overdose deaths 
from prescription opioids.1, 4  In 2008, prescription opioid-related overdose deaths in the U.S. 
accounted for 73.8% of the 20,044 prescription drug overdose deaths and accounted for 40.6% 
of the 36,450 overall drug overdose deaths.4 
In 2010, legislators and public health officials responded to this alarming trend by 
implementing a series of criminal justice and public health interventions, which worked to 
reduce the rising prevalence of prescription opioid-related overdose deaths.1 An abuse-
deterrent formulation, which is more difficult to crush, inject, and inhale, replaced long-lasting 
oxycodone;5, 6 propoxyphene was removed from the market;1 and prescription drug monitoring 
programs were established to enhance accountability and promote safer prescription 
practices.7, 8, 9 Legislators passed restrictions on high-volume opioid prescriptions within pain 
management clinics, as well as requirements for medical examinations and follow-ups when 
prescribing opioids for chronic pain.10, 11, 12, 13 Communities began to implement community 
overdose education and naloxone rescue programs to reduce the prevalence of prescription 
opioid-related overdose deaths. The expansion of these programs across the country led to the 
near-ubiquitous nationwide adoption of legislation supporting naloxone provision to citizens by 
2016.14
Heroin and Synthetic Opioids
Though efforts to reduce prescription opioid abuse throughout the 2010s exhibited a 
certain degree of success, it was insufficient to prevent the catastrophic wave of substance 
use disorder and addiction set into motion by the opioid prescribing practices of the previous 
decade.1 The introduction of abuse-deterrent formulations ensured that users could not 
circumvent the extended-release properties of prescription opioids to produce an intense short-
term high. At the same time, legislative reform efforts restricted access to previously obtainable 
prescription opioids. While the newly adopted measures succeeded in reducing opioid access, 
they often failed to address the widespread misuse of and addiction to these medications. 1, 6 
Individuals with opioid use disorder transitioned to using a more readily available and cheaper 
substitute: heroin. 5, 6, 15, 16 Thus, these measures unintentionally facilitated a national shift from 
prescription opioid abuse to illicit opioid abuse.
Prior prescription opioid abuse among active heroin users has been well documented, 
suggesting the overzealous opioid prescribing patterns of the 2000s and subsequent public 
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health interventions had a direct influence on the exponential increase in heroin overdose 
deaths.17, 18, 19, 20 From 2004 to 2010, the number of active heroin users who reported 
prescription opioid abuse prior to heroin initiation increased from approximately 64% to 80%.17, 
18, 19 Relative to the steady increase which occurred throughout the 2000s, heroin overdose 
deaths increased by 500% throughout the 2010s, peaking in 2017 with 15,482 deaths.21, 22 
The ever-increasing demand for heroin throughout the early 2010s severely impacted 
existing illicit narcotic supply chains.20 A third opioid mortality wave rapidly emerged in 2013 
with the introduction of illicitly manufactured synthetic opioids (e.g., fentanyl and fentanyl 
analogs) as a means of adulterating heroin supply chains.20, 23, 24, 25 Featuring a similar potency 
to fentanyl produced legally in commercial pharmaceutical laboratories, illicitly manufactured 
fentanyl provided a cheap alternative that could be produced as a powder to supplement or 
substitute for heroin to extend supplies, or as a tablet to mimic less potent opioids.26 With a 
potency 40 times greater than heroin, illicitly manufactured fentanyl’s lighter weight and volume 
allow for easier transportation and distribution than heroin.1 Though initially introduced through 
heroin supply chains, evidence suggests illicitly manufactured fentanyl has also penetrated 
supply chains for counterfeit pharmaceutical pills and cocaine. 25, 26, 27, 28
While illicitly manufactured fentanyl and heroin have a similar half-life of 3 to 7 hours, 
the stronger potency and faster metabolic rate of fentanyl produce a more intense high and 
allow the user to abuse it more frequently.1 As a result, fentanyl-related overdose deaths 
have increased at an alarming rate.  From 2013 to 2015, U.S. drug overdose deaths involving 
synthetic opioids other than methadone (a statistical category overwhelmingly dominated by 
fentanyl and fentanyl analogs) increased by 209%.25  Evidence suggests these estimates likely 
undercount overdose deaths involving synthetic opioids like fentanyl, as approximately one-fifth 
of death certificates fail to list any specific drug involved in the fatal overdose.29 
Contemporary Local Trends
East Baton Rouge Parish recently began to reflect earlier national trends in opioid 
prescribing patterns, as well as opioid-related morbidity and mortality. From 2016 to 2019, the 
number of opioid prescriptions issued to patients residing within East Baton Rouge Parish 
decreased by approximately 22% (see Figure 1). 
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FIGURE 1. PRESCRIPTIONS ISSUED BY PATIENT RESIDENCE
EAST BATON ROUGE, 2016-2019
In addition to the declining number of opioid prescriptions, the potencies of opioid 
prescriptions issued to East Baton Rouge Parish residents have substantially decreased over 
the past 4 years. On average, the morphine milligram equivalent of opioid prescriptions issued 
to East Baton Rouge Parish residents decreased by approximately 33% from 2016 to 2019 (see 
Figure 2).
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FIGURE 2. AVERAGE MORPHINE MILLIGRAM EQUIVALENT (MME) 
PER OPIOID PRESCRIPTION
EAST BATON ROUGE, 2016-2019
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Despite the decline in the amount and potency of opioid prescriptions issued to East 
Baton Rouge Parish residents over the past 4 years, opioid poisoning-related emergency 
department visits in East Baton Rouge Parish have substantially increased. From 2014 to 2018, 
opioid poisoning-related emergency department visits increased by approximately 45% (see 
Figure 3). During this 5-year period, heroin poisoning-related emergency department visits 
increased by approximately 30%. Even more disturbing, non-heroin opioid poisoning-related 
emergency department visits increased by 59%. 
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FIGURE 3. OPIOID POISONING-RELATED EMERGENCY 
DEPARTMENT VISITS
EAST BATON ROUGE, 2016-2019
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Note: 2019 data were not available for opioid poisoning-related ED visits.
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Reflective of national trends, East Baton Rouge Parish opioid-related overdose deaths 
from 2018 to 2019 disproportionately occurred among individuals who were white (72%) and 
male (67%). During this time period, the majority of individuals who died of opioid overdose 
were between 30 and 44 years old (67%). Rapid increases in opioid overdose deaths remain 
a cause for concern. From 2018 to 2019, opioid overdose deaths in East Baton Rouge Parish 
increased by approximately 29% (see Figure 4). Opioid overdose deaths have consistently 
accounted for nearly all overdose deaths in East Baton Rouge Parish during this time frame. 
Though 2020 data are not included in the figures of this report, as they are incomplete and 
cannot yet be compared to 2018 — 2019 data, it is worth noting the continued steep rise of 
overdose deaths in East Baton Rouge Parish. Alarmingly, opioid overdose deaths between 
January to June 2020 increased by 113% compared to the same months the year before. By 
August 2020, East Baton Rouge Parish experienced more opioid overdose deaths than in all of 
2019. These data necessitate further action to reduce the impacts of opioid misuse within the 
community.
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FIGURE 4. OVERDOSE DEATH TRENDS
EAST BATON ROUGE, 2018-2019
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Criminal justice practitioners (e.g., law enforcement, correctional officials, defense attorneys, 
prosecutors, court officials) have an important role in reducing opioid-related addiction, 
overdose deaths, and violence within East Baton Rouge Parish communities. Individuals with 
substance use disorder are often fearful of interacting with law enforcement due to the belief 
that they will be arrested for their addiction, decreasing the likelihood that these individuals 
will reach out for critical treatment. Therefore, public health officials can be reluctant to include 
criminal justice practitioners in substance use disorder reduction efforts, despite their ability to 
engage in meaningful, productive partnerships. For these perceptions to change, criminal justice 
practitioners must demonstrate a commitment to addiction and overdose prevention by forming 
vital partnerships and supporting their partners’ prevention efforts to address this epidemic. 
In October of 2018, the Office of the District Attorney for the 19th Judicial District in East 
Baton Rouge was awarded the IPS grant by the U.S. Department of Justice, Office of Justice 
Programs, Bureau of Justice Assistance. The goal of the IPS grant is to reduce opioid-related 
deaths by fostering inter-agency collaboration to disrupt local opioid supply chains, educate the 
community about the dangers of opioid abuse and addiction, and provide support for individuals 
with opioid use disorder. The current agencies involved in the IPS partnership are listed in the 
Appendix. The following sections describe IPS approaches and activities to address opioid 
overdose prevention.
Overdose Death Response and Investigation Protocols
The IPS grant recognizes that arresting users and individuals with substance use 
disorders will not improve our community’s addiction problem. Instead, an emphasis should 
be placed on identifying the suppliers that have worsened and exacerbated the problem. Law 
enforcement should implement consistent overdose death investigation protocols that treat 
every overdose death scene as a potential homicide (rather than dismiss overdose deaths as 
a victim-less crime), allowing for a thorough investigation with an emphasis on the retention 
and preservation of evidence. Doing so enhances overdose investigations and supports future 
BEST PRACTICES FOR OPIOID OVERDOSE PREVENTION AND 
THE ROLE OF CRIMINAL JUSTICE PARTNERSHIPS
IPS EFFORTS
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prosecutions. Responding officers should be cognizant of the unique forms of evidence critical 
to successful prosecution, specifically the collection and forensic extraction of data from mobile 
devices. Furthermore, officers should be mindful of the need to work in a cooperative and 
coordinated effort with the coroner’s office at the scene.
Enhance Use of Data Tools in Law Enforcement 
Understanding the full extent of the opioid epidemic is essential to know which programs 
to implement and where to implement them. Officials and leaders must rely on coordination 
and information sharing between agencies. The ability to access real-time, pertinent information 
through robust surveillance, monitoring, and data analysis can better prepare criminal justice 
agencies’ responses. The following details a few examples of the analytical tools and products 
proposed by the IPS grant:
Geographic Information System (GIS) Mapping Software allows analysts to draw upon 
local data to understand the spatial distribution of narcotic incidents and opioid overdose 
fatalities throughout a specific geographic region. Descriptive spatial analyses can be used to 
develop maps delineating areas with the greatest need for attention and assistance. Inferential 
spatial analyses can be used to find factors associated with geographic patterns in incidences 
or fatalities, and to generate maps that forecast vulnerable areas. Employing these techniques 
offers the opportunity for criminal justice agencies to proactively address the opioid epidemic 
by identifying locations for tailored crime reduction, community policing, and harm reduction 
strategies.
Figures 5 – 10 are examples of GIS maps detailing data trends that criminal justice 
agencies can use to understand the full scope of the opioid epidemic within local communities. 
These maps used data from IPS partners to highlight the areas experiencing the greatest 
problems and needs. Many of these maps illustrate the interrelated issues of the complicated 
and changing nature of overdoses over time. 
Figures 5 – 8 illustrate the increase and spread of opioid overdoses across East Baton 
Rouge Parish from 2018 to 2019, according to emergency medical service (EMS) records and 
911 calls. Figures 9 and 10 illustrate the decrease in opioid prescriptions per parish resident from 
2018 to 2019.
13
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FIGURE 5. COMPUTER-AIDED DISPATCH (CAD) CALLS WITH (POSSIBLE) OVERDOSE, 
EAST BATON ROUGE PARISH, 2018
     
  
FIGURE 6. COMPUTER-AIDED DISPATCH (CAD) CALLS WITH (POSSIBLE) OVERDOSE
EAST BATON ROUGE PARISH, 2019
Note: Records include all CAD 
calls indicating overdose deaths 
and possible overdose deaths.
Source: SREC Database;
Map by G. Richardson
Kernel Density
Kernel Density
Note: Records include all CAD 
calls indicating overdose deaths 
and possible overdose deaths.
Source: SREC Database;
Map by G. Richardson
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FIGURE 7. EMS OPIOID IMPRESSIONS (OVERDOSE DEATHS ), EAST BATON ROUGE PARISH, 2018
FIGURE 8. EMS OPIOID IMPRESSIONS (OVERDOSE DEATHS). EAST BATON ROUGE PARISH, 2019
Opioid Impressions 
per Zip Code
Note: Total number of opioid 
impressions Jan-Dec 2018 (1806)
Source: SREC Database;
Map by G. Richardson
Opioid Impressions 
per Zip Code
Note: Total number of opioid 
impressions Jan-Dec 2019 (1844)
Source: SREC Database;
Map by G. Richardson
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FIGURE 9. OPIOIDS BY PATIENT (MME PER PRESCRIPTION) PER ZIP CODE
EAST BATON ROUGE PARISH, 2018 (YEARLY AVG.)
FIGURE 10. OPIOIDS BY PATIENT (MME PER PRESCRIPTION) PER ZIP CODE
EAST BATON ROUGE PARISH, 2019 (YEARLY AVG.)
Opioids by Patient
MME/Prescription
Note: MME is Morphine Milligram Equivalent; 
MME per opioid prescriptions by “patient” 
location (zip code). Using the AHFS 
Classification, Opiate Agonists and Antitussive 
were selected and then filtered to include only 
opioids. Opioid Partial Agonists (ie. 
Suboxone, Buprenorphine, etc.) were not 
included, n/a = removed zip code(s) in 
compliance with state law regarding de-
identified information. SREC Database;
Map by G. Richardson
Opioids by Patient
MME/Prescription
Note: MME is Morphine Milligram Equivalent; 
MME per opioid prescriptions by “patient” 
location (zip code). Using the AHFS 
Classification, Opiate Agonists and Antitussive 
were selected and then filtered to include only 
opioids. Opioid Partial Agonists (ie. 
Suboxone, Buprenorphine, etc.) were not 
included, n/a = removed zip code(s) in 
compliance with state law regarding de-
identified information. SREC Database;
Map by G. Richardson
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Social Network Analysis encompasses a multitude of analytical techniques that describe 
the social relationships (if any) among actors involved in law enforcement narcotic incidents. 
These techniques help identify ties among individuals involved in the manufacturing, supply, 
and distribution of illicit opioids, as well as individuals with ties to victims of overdose and 
drug-related homicides. Using these techniques to develop social network maps provides an 
illustration of the illicit drug market structure and allows law enforcement to prioritize which 
suspects would be most beneficial to engage. This approach provides valuable insight into 
distribution supply chains operating within East Baton Rouge Parish, identifies key actors 
associated with each distribution access point, and potentially allows law enforcement to disrupt 
the network. By working with data analysts to develop these products, law enforcement can 
more efficiently distribute agency resources for investigation and enforcement operations. 
Uniform Device Forensic Extraction Techniques use proprietary technology to locate, 
access, and extract data stored within cellphones and mobile devices (e.g., geolocation data, 
communication logs, social media information). These techniques may only be used under 
justifiable, ethical conditions with the issuance of a judicial warrant to execute a search of 
mobile devices. Using mobile device forensic extraction techniques, law enforcement can 
rapidly obtain information at the scene of an overdose death, which may provide useful to 
multiple investigations. Archived data on mobile devices may be used to trace illicit opioid 
suppliers via phone calls and text messages, as well as public and private interactions through 
social media applications. This information helps investigators understand illicit drug markets 
by providing historical transaction patterns and critical evidence for prosecution efforts against 
manufacturers, distributors, and suppliers. For this technique to be useful, law enforcement 
needs adequate staffing with proper training and expertise in using uniform device forensic 
extraction technology to perform forensic analysis and develop timely reports to enhance 
investigatory and prosecution capacity.
Educate the Community on the Dangers of Opioids and Opioid Addiction
Beyond simply disrupting illicit opioid supply chains, criminal justice agencies have 
several important roles in reducing the demand for illicit opioids within local communities. These 
roles include, but are not limited to: 
•	 Enhancing public awareness regarding the opioid epidemic; 
•	 Educating local communities about opioid abuse and addiction; 
•	 Participating in programs that reduce the availability of unused prescription opioids within 
local communities; and 
•	 Identifying potential individuals to link with appropriate treatment programs and care 
facilities. 
17
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The following information outlines the various strategies employed by the IPS grant to 
engage with each role.
Public Relations Campaign
IPS grantees and partners developed a public relations campaign via radio, social media, 
and a web page targeting the populations most susceptible to opioid overdose fatalities within 
East Baton Rouge Parish. The campaign aimed to increase awareness of the opioid epidemic 
and patterns of addiction, and to provide information on how to reduce opioid exposure within 
their communities.
Community Forums
To increase community awareness of the opioid epidemic, IPS grantees and partners 
are planning to host a series of community forums presenting data about the drastic increase in 
opioid abuse and opioid overdose fatalities in East Baton Rouge Parish, as well as educational 
material detailing the risks of opioid addiction and methods to prevent opioid abuse. Through 
these community forums, partners will share information about the safe use and disposal of 
prescription opioids through the means of medication drop box locations or DEA Take Back Day 
programs. They will also share resources concerning community treatment options, including 
how to identify and enroll in appropriate treatment programs. In addition, partners will also offer 
information about naloxone distribution sites and training programs. 
Push cards
IPS grantees and partners are developing informational cards containing relevant 
overdose resources to distribute among community forum participants, as well as among 
survivors, family members, friends, and witnesses at the scene of an opioid overdose. These 
cards will provide crucial information in case of an opioid overdose, including instructions 
for proper naloxone administration, community treatment resources, and coroner contact 
information in the case of an opioid overdose fatality. 
The Good Samaritan Law
IPS intends to publicize the Good Samaritan Law as part of community education efforts. 
Fear of arrest and prosecution presents a significant barrier to individuals seeking medical 
assistance in the event of an overdose. The legal immunities provided by Good Samaritan laws 
vary from state to state, ranging from broad immunities that prevent arrest and prosecution, to 
partial immunities. 
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In general, Good Samaritan laws may provide a degree of medical amnesty for:
•	 Individuals seeking medical attention for another individual experiencing a drug-related 
overdose; 
•	 Individuals experiencing a drug-related overdose; 
•	 Bystanders in possession of drugs or drug paraphernalia; and
•	 Medical providers who prescribe or administer opioid reversal medication.
Currently, the Louisiana Good Samaritan laws provide immunity to individuals who 
need medical assistance for a drug-related overdose. Specifically, the immunity applies to 
charges, prosecution, or penalties for possession of a controlled dangerous substance, as 
defined by the Uniform Controlled Dangerous Substance Law, if evidence was obtained as 
a result of the overdose and call for medical assistance (La. Rev. Stat. Ann. § 14:403.10).30 
These protections extend to individuals acting in good faith who seek medical assistance for 
an individual experiencing a drug-related overdose, so long as this person did not illegally 
provide or administer the controlled dangerous substance.31 Although these provisions prevent 
individuals from being prosecuted and sentenced, these individuals are not shielded from arrest 
for possession of a controlled dangerous substance. Additionally, the Louisiana Good Samaritan 
laws provide immunity from criminal and civil liability to medical providers who prescribe 
naloxone, pharmacists who dispense naloxone, and any individual who administers naloxone to 
a person believed to be experiencing an opioid-related overdose (La. Rev. Stat § 40:978.2).32 
Though evidence suggests Good Samaritan laws reduce overdose fatalities, the laws 
are only effective if the general public and those most susceptible to drug-related overdose 
are aware of their existence.31 To our knowledge, no study has been conducted in East Baton 
Rouge Parish to examine public awareness of the Louisiana Good Samaritan laws. Push cards 
and community forums (especially in “hotspot” neighborhoods) providing education about Good 
Samaritan laws and the use and availability of naloxone are two ways to share this information 
so that it is publicly known and understood by the community. 
DEA Take Back Day
Public education on the importance of safely storing and disposing prescription 
pain medication, and giving them the ability to do so, reduces access to opioids within the 
community. Twice per year, the Drug Enforcement Administration (DEA), an active partner of 
the IPS grant, hosts national and local Take Back Day events to encourage citizens to bring 
unused and expired medication to predetermined locations for proper disposal. Criminal justice 
agencies can actively participate in these events by encouraging public participation, as well 
19 Social Research  & Evaluation Center, Louisiana State University
as hosting drug disposal boxes for continuous disposal of unused or expired opioids and other 
types of medication. 
Prescription Monitoring Program (PMP)
As an active partner of the IPS grant, the Louisiana Board of Pharmacy provides data 
from the Prescription Monitoring Program (PMP) to describe opioid prescribing patterns. 
Ensuring prescribers receive proper training and education, as well as access to use the PMP 
portal, protects patients and physicians from the dangers associated with over-prescribing. 
Louisiana law requires prescribers to consult the PMP portal to review and monitor each 
patient’s opioid prescription history prior to and during treatment, with some exceptions (La. Rev. 
Stat. § 40:978).32 Prescribers should be encouraged to comply with the PMP, as the database 
serves as an important tool to prevent doctor shopping and the over-prescribing of opioids and 
other addictive substances.33
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The following criminal justice programs have shown effectiveness for individuals experiencing 
opioid use disorder. Some programs are already being implemented to some extent in East 
Baton Rouge Parish, while some have not yet been considered. 
Drug Courts – Diversion and Reentry
Drug courts (i.e., specialized courts designed to handle non-violent offenders with 
substance use disorders) combine substance use treatment with the legal and moral authority of 
the court to disrupt the cycle of substance use and drug-related crime.34, 35, 36, 37 Implemented 
for pre- and post-adjudication efforts, drug courts provide candidates with a series of 
requirements to be completed in exchange for: a) reduced or dismissed charges; b) release on 
condition of probation; or c) release on condition of parole.36 Upon referral and screening for 
program eligibility, candidates who agree to participate are expected to abide by various court 
mandates, which consist of regular appearance before the court for status hearings, as well as 
adherence to a comprehensive treatment regimen addressing substance use, mental health, 
education, and employment.36, 37, 38, 39, 40 
Since drug court programs are multiphasic, status hearings provide an essential forum for 
judges and various court staff to engage with participants about their individualized treatment 
plans and progress.36, 37 By implementing the principle of graduated sanctioning and rewards, 
the authority of the court is used to motivate program compliance.36, 39, 41 Participants who 
adhere to the court mandates advance through three or more progressively less intense phases 
before completing the program, culminating in a formal graduation ceremony upon successful 
completion of drug court.37, 39 Participants who fail to adhere to the court mandates are 
gradually sanctioned with each subsequent failure to comply. 37, 39  As a last resort, participants 
who fail to adhere to court mandates may be dismissed from the program and incarcerated. 37, 
39, 40
Pre-adjudication drug courts emphasizing diversion typically have a 6- to 12-month 
duration. In contrast, post-adjudication drug courts focusing on community reentry are longer-
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term, lasting upwards of 12 months.37 Evidence suggests drug court programs that last between 
8 to 16 months provide the best outcomes regarding recidivism.42, 43  Programs may face 
challenges regarding recruitment and retention fo appropriate participants due to the length 
and difficulty of this process. Though drug courts may vary in terms of programmatic guidelines, 
the key components of drug courts are: 
•	 Collaborative, non-adversarial, outcome driven court processing;
•	 Early identification of eligible participants;
•	 Substance use treatment integrated with criminal justice case processing;
•	 Frequent urinary analyses;
•	 Judicial monitoring; and
•	 Implementation of graduated sanctioning and rewards.35, 36, 39 
Evidence suggests adult drug courts significantly reduce the likelihood of three-year recidivism 
for general offenses and drug-related offenses.37 Conversely, juvenile drug courts have 
been demonstrated to significantly reduce the likelihood of three-year recidivism for general 
offenses.37 
Pre-Release and Post-Release Treatment Services
Drug overdose is the leading cause of death among formerly incarcerated individuals 
in the initial two years following release.44 Relative to the general population, formerly 
incarcerated individuals exhibit higher rates of fatal overdose, experiencing a 3- to 8-fold 
increase in the risk of opioid-related mortality within the first 2 weeks of release, which is 
sustained throughout the first month of community reentry.44, 45 It is imperative to consider 
the roles of pre-release and post-release treatment services within the continuum of care for 
incarcerated individuals.46 
Pre-release treatment services (i.e., substance use treatment services delivered 
throughout a term of incarceration) offer a prime opportunity to engage opioid-dependent 
incarcerated individuals with sustainable recovery options that can continue upon release.47, 48 
Though a variety of programs exist, a substantial amount of evidence suggests implementing 
the following three interventions during incarceration effectively reduces subsequent substance 
use and recidivism: 
•	 Cognitive behavioral therapy;
•	 Therapeutic communities; and 
•	 Medication-assisted treatment (MAT).47, 49
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Each program exists within correctional and community settings, allowing law enforcement 
to collaborate with local service providers prior to an individual’s release to establish a post-
release treatment plan that ensures continual access to care.47 
Post-release services focus on continuing and expanding treatments that were initiated 
during incarceration, and address negative outcomes in the weeks following release. One 
example is Prison Take-Home Naloxone programs, which provide naloxone training and devices 
to individuals at the time of release to help reduce overdose deaths. These programs have high 
participation rates among individuals with a history of injection drug use,50 and are associated 
with a 36% reduction in drug overdose deaths in the first four weeks post-release from prison.51 
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The following describes practices and programs implemented in the wider community that 
would benefit from the participation and support of criminal justice practitioners. Each of these 
practices require community partnerships to reduce recidivism, overdose deaths, and other 
negative individual and societal consequences of opioid misuse. 
Harm reduction
Harm reduction strategies are important components for comprehensive interventions 
which mitigate the negative health consequences of opioid misuse and opioid use disorder. 
Implemented before and during treatment, these strategies reduce physical harm and mortality 
by integrating education with a linkage to resources.
Through the Louisiana State Opioid Response (LaSOR) federal grant, Capital Area Human 
Services (CAHS) in Baton Rouge launched an Opioid Mobile Outreach Team and a mobile 
crisis unit in early 2020 which travels among opioid overdose hot spots to provide addiction 
counseling, medication-assisted treatment, naloxone distribution, laboratory testing, and needle 
exchange services.52 This section describes the importance of law enforcement and community 
support to sustain and expand these harm reduction efforts.
On scene use of naloxone and other medications to reverse overdose
Naloxone (Narcan, Evzio) is an FDA-approved medication used to block or reverse the 
effects of an opioid overdose quickly and safely, thereby preventing overdose fatalities. There is 
no potential for addiction or abuse of the medication. Naloxone can be used without harm to the 
victim of the overdose even if the cause of the overdose is unknown. If it is available, naloxone 
can be administered immediately to the overdose victim at the time and place of the overdose. 
Education efforts are needed along with naloxone dosing as emergency medical care is usually 
also required. Making naloxone available to heroin users has not been shown to increase drug 
use.53 
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Empirical evidence establishes naloxone distribution as an effective intervention for 
preventing opioid overdose deaths.54 Naloxone must be administered promptly once overdose 
occurs to be effective. Therefore, it is essential to provide naloxone and training on its use to 
bystanders and first responders, including firefighters and police officers who may arrive on 
scene before paramedics. In 2018, the U.S. Surgeon General55 released an advisory for the 
following groups to have naloxone within reach and know how to administer it:
•	 First responders including paramedics, police officers, and fire fighters;
•	 Patients prescribed a high dose of opioids for pain management;
•	 Individuals misusing opioids, including prescription opioids and illicit opioids (e.g., heroin 
or fentanyl);
•	 Family and friends of individuals with opioid use disorder; and
•	 Healthcare providers. 
Other communities and states have successfully prevented opioid overdoses by 
providing naloxone and training first responders and non-medical bystanders.56 Training 
includes the signs of overdose and how to administer naloxone, as well as the importance for 
bystanders to call 911 as soon as they recognize an overdose is occurring. SAMHSA57 published 
the Opioid Overdose Prevention Toolkit, which is publicly available on their website, for 
prescribers, community members, patients recovering from opioid use disorder, and the families 
of individuals with opioid use disorder. The toolkit can be used by health trainers to educate 
about opioids and how to prevent overdose, recognize overdose, and administer naloxone. The 
toolkit also discusses strategies for community and local governments to prevent opioid deaths, 
including ensuring that naloxone is readily available.
Naloxone can be administered by injection or intranasally. EVZIO® is an auto-injectable 
device pre-filled with a dose of naloxone and can be purchased without a prescription.58 
However, it is costly at $4,100. The nasal spray, NARCAN®, comes in a kit which includes two 
doses. Narcan kits cost an average of $140 each without insurance, though this may be lower 
for law enforcement.59 Generic naloxone averages around $40 per dose. Prescription coverage 
of naloxone varies depending on the diagnosis and an individual’s medical coverage. Therefore, 
it is important to bring in community partners to ensure resources are provided to both first 
responders and those at-risk of overdose to obtain naloxone.
Leave Behind Naloxone Program
Individuals who have experienced an overdose are at risk for another overdose incident. 
Expanding upon the naloxone administration by bystanders, another best practice includes 
leaving behind a naloxone kit with at least one dose and instructions for use with someone who 
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has overdosed or a loved one.59 These interventions commonly use a combination of training 
EMS to teach patients and families how to use naloxone kits that they “leave behind” and link 
patients to substance use treatment. Other similar models, called “take home” programs, entail 
the provision of naloxone and training to overdose victims and family members by emergency 
department staff.60 
Needle and syringe exchange programs
The rise in opioid addiction and subsequent increase in injection drug use has been 
linked to increases in Hepatitis C infections in the U.S.,60 as well as community outbreaks of 
HIV.61, 62 The U.S. Surgeon General55 and the American Medical Association63 recommend 
that needle exchange programs be established in all communities. These programs generally 
provide clean needles and safe disposal of used needles, as well as lab testing for HIV and 
Hepatitis C, health education, linkage to substance use treatment, mental health and medical 
services, and social services.64 Needle exchange and syringe exchange programs have been 
shown to be effective in reducing the transmission of infectious diseases (such as Hepatitis C 
and HIV) resulting from sharing needles, as well as serving as a bridge to addiction treatment.65, 
66 Moreover, injection drug users who participate in these types of programs are more likely to 
seek treatment than those who do not participate.65 
In 2017, Louisiana legalized syringe exchange programs but allowed individual 
communities to decide whether these programs should be made available to residents in 
their parishes.67 That same year, the East Baton Rouge Metropolitan Council changed a parish 
ordinance in order to allow needle and syringe exchange programs for its residents. New 
Orleans, Alexandria, and Shreveport have passed similar ordinances.67, 68 
Fentanyl testing kits
The dramatic rise of overdose deaths in the U.S. since 2015 has been attributed to the 
illegal manufacturing and use of the synthetic opioid fentanyl, which is mixed with heroin and 
other drugs such as cocaine to increase its potency.69 A person who buys illicit drugs has no 
way of knowing by looking at the drug whether it contains fentanyl and if so, how much, thus 
also leaving the person unaware of the odds of overdose.
Fentanyl Test Strips (FTS) have increasing popularity in community harm reduction 
programs. They work by diluting a small amount of drug with water and dipping a test strip into 
the mixture.70 Within a few minutes, an indicator on the test strip appears if fentanyl is detected. 
The strips are inexpensive and highly accurate. While the evidence of their overall efficacy is still 
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limited, studies show that there is a willingness among people who inject drugs to use FTS to 
inform behaviors that prevent overdose.71, 72 
Treatment and Recovery Support
Expanding access points to screening, referral, and treatment
Timely screening, referral, and treatment are important factors in decreasing deaths from 
opioid overdose for those with opioid use disorder. While post-release programs are essential, 
not all who need addiction services encounter the criminal justice system. Criminal justice 
practitioners and their community partners (Emergency Medical Services, hospital emergency 
departments, treatment providers, primary care and specialty physicians and prescribers, dental 
and allied health professionals, and concerned community members) can work together to 
link potential candidates to treatment. Each of these partners represent a possible access point 
to a person with addiction. Ensuring the provision of appropriate screening for opioid misuse, 
resources, and referral to treatment at multiple access points expands outreach to a broader 
population more frequently. 
An important group to include in this effort are first responders who are often repeatedly 
sent to the same addresses and administer naloxone to the same individuals. These first 
responders have first-hand knowledge of who could benefit from treatment in our community. 
This knowledge makes our first responders an excellent referral source to treatment in the 
community.
Community-based Medication-Assisted Treatment (MAT)
Due to the nature of drug dependence and its lasting effects on the brain, addiction 
should be considered and treated as a chronic medical illness.73 The complex causes and 
effects of addiction, including genetics and environment, require multi-modal, long-term 
strategies to achieve treatment retention. Medication-Assisted Treatment (MAT) involves the 
use of medications such as methadone, buprenorphine, or extended-release naltrexone. MAT 
is effective in treating both prescription opioid and heroin addiction. MAT is associated with 
higher retention rates, especially when combined with behavioral therapy.74 Community-based 
MAT uses medication in combination with counseling and behavioral therapies to provide a 
“whole-patient” approach to the treatment of substance use disorders.75 Research shows that a 
combination of medication and behavioral therapy can successfully help individuals struggling 
with addiction sustain recovery.76, 77 
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Despite its effectiveness, MAT has been slow to expand due to a long-standing 
preference for outdated models of abstinence-only treatment. It was only in 2019 that Capital 
Area Human Services (CAHS) began to offer MAT for individuals with opioid use disorder.52 
Due to the scarcity of MAT providers, many individuals seeking treatment face the possibility 
of traveling long distances to access their provider, which could greatly affect retention.78 
Therefore, other settings such as primary care clinics, Federally Qualified Health Centers, and 
mobile units have begun to provide MAT to individuals in their own communities. Studies show 
that primary care clinics can be effective in providing MAT for maintenance treatment.78 The 
LaSOR grant began to offer MAT to East Baton Rouge residents through its mobile unit in early 
2020.52
Peer recovery programs
Peer recovery support programs use a continuum of care, chronic illness approach 
to recovery,79 and provide a bridge between the previously mentioned points of access and 
treatment. They are implemented by Peer Recovery Support Specialists (PRSS), individuals who 
have experienced addiction and recovery and are trained to offer various forms of peer support 
to individuals with addiction. PRSSs perform an array of services, including education on and 
provision of naloxone; referrals to medical treatment, addiction treatment, needle exchange 
programs, and community services (including housing, food, and employment resources); 
assistance with accessing resources and treatment; support in developing personalized 
recovery plans and goal setting; and non-clinical emotional support from the perspective of 
someone who has experienced addiction and the recovery process.79, 80 Peer recovery support 
programs are most effective when PRSSs are well-trained and their involvement is integrated 
across each stage of recovery, from pre-engagement into treatment through recovery 
maintenance.80, 81, 82 
Organizations and communities have successfully implemented peer-based support 
programs in a variety of settings where individuals with drug use disorders are already engaged: 
hospital emergency departments, community outreach programs, recovery centers, drug courts, 
prisons, parole and probation programs, churches, sober living and recovery support homes, 
and addiction treatment centers. 79
Other Community-Based Programs
Public Health and Safety Teams (PHAST)
The Public Health and Safety Team (PHAST) program uses a public health and public 
safety partnership approach. The program conducts overdose fatality reviews with multi-
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agency partners. These partners identify changes and plans for targeted responses and 
actions that can prevent future overdoses. The PHAST partners make recommendations 
to reduce barriers for agencies to implement changes, help meet the needs for addiction/
overdose problems, and related issues. The decision makers in these agencies can leverage 
connections and relationships to make appropriate changes and support implementation of 
the recommendations. The PHAST partners generally consist of community, public health, 
and public safety agencies. A team of those responsible for the day-to-day agency activities 
generally make recommendations for an administration-level (i.e., sheriff, hospital administrator, 
District Attorney) team to implement.
The CDC’s PHAST Toolkit Version 2.0 was released in March 2020 for download and 
dissemination. While there is no empirical evidence of the PHAST model’s impact on reducing 
overdoses, overdose fatality reviews are growing in popularity and are increasingly being used 
across the country. 
Overdose Detection Mapping Application Program (ODMap)
ODMap is a mapping surveillance application tool that can be used to detect spikes 
and locations of overdoses in real-time in the community and shared across jurisdictions using 
the application. First responders enter data from the scene of overdoses that are mapped and 
shared with public health and public safety officials. By quickly identifying overdose hot spots, 
officials can quickly alert the public, identify the source of the overdoses, and coordinate and 
deploy harm reduction resources to prevent more overdoses. 
In Rhode Island, the AnchorMORE program is able to use surveillance data to target 
the deployment of several programs mentioned in this document, including Peer Recovery 
Specialist teams, naloxone distribution and education, and referral services to resources and 
addiction treatment.79 Specifically, AnchorMORE used data surveillance of opioid deaths to 
determine how many naloxone kits should be distributed in each town. 
When known, drug suppliers causing fatal overdoses are an important source of 
public health information that should be shared with the dealers’ other contacts and buyers 
of the potential deadly batch. While not using the ODMap application, specifically, mapping 
surveillance was shown to be an effective tool for the deployment of resources when the 
location of overdose hot spots was known to public officials in real-time. The ODMap application 
information and program implementation training manuals are available at ODMap.org. 
29 Social Research  & Evaluation Center, Louisiana State University
This report highlighted national and local trends concerning the opioid epidemic, as well as 
detailing IPS proposals for innovative criminal justice efforts. Though the proposed measures 
provide an important foundation, a review of contemporary evidence-based practices suggests 
that additional actions are required to comprehensively address opioid-related overdoses and 
violence. The following recommendations and action items should be considered by criminal 
justice practitioners regarding intervention development and implementation.
Recommendation: Implement Departmental Protocols Regarding 
Possession and Use
Departmental protocols should be implemented concerning discretionary law enforcement 
responses to the possession and use of illicit opioids. Rather than arresting individuals solely 
for small amounts of drugs and drug paraphernalia indicative of personal use, departmental 
protocols should emphasize linking individuals to community programs (such as Peer Support 
Specialists) and obtaining cooperation which would enhance the ability to pursue those 
responsible for manufacturing, supplying, and distributing illegal narcotics in the community.
Recommendation: Continue to Utilize Federal Law Enforcement Levers
Criminal justice agencies should continue to leverage federal law enforcement partnerships to 
access the investigatory and prosecutorial resources available to East Baton Rouge Parish as a 
High Intensity Drug Trafficking Area (HIDTA) to pursue cases involving manufacturers, suppliers, 
and distributors.
Recommendation: Identify and Monitor Social Networks Using 
Social Media Data 
Criminal justice agencies should use data scraping techniques and social network analysis to 
identify patterns of illicit drug sales occurring on public social media. This information can assist 
law enforcement in understanding the structure of local illicit drug networks, as well as form the 
basis of actionable intelligence.
RECOMMENDATIONS FOR FUTURE ACTION
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Recommendation: Develop a Forensic Certification-Based 
Collegiate Internship
Criminal justice agencies should develop a collegiate internship program in which law 
enforcement provide local college students with the necessary training to receive a uniform 
forensic analyst certification (e.g., Cellbrite Analyst Certification), as well as professional 
experience utilizing this training within a Crime Strategies Unit or local law enforcement 
agency. Though training and certification costs would be associated with the implementation, 
this program would be mutually beneficial to criminal justice agencies and collegiate interns. 
This program would enhance the investigatory and prosecutorial capacities of criminal justice 
agencies by aiding in the extraction, analysis, and reporting of data acquired from mobile 
devices, while providing interns with valuable training and experience which can assist them 
with future employment.
Recommendation: Provide Appropriate Referrals to Drug Court 
IPS partners should refer potential participants to the District Attorney for the 19th JDC Drug 
Court treatment and diversion program. Through calls for overdose assistance, law enforcement 
and first responders are informed referral sources for individuals suffering from substance use 
disorders who can benefit from the services provided by the diversion process.
Recommendation: Establish a Prison Take Home Naloxone Program
Parish and state correctional facilities should distribute naloxone upon release to individuals 
who have a history of substance use disorder, overdose, or charges pertaining to drug use, as 
well as provide training on proper naloxone administration, to reduce overdose deaths after 
release. This is recommended if it is allowable by the State of Louisiana’s Standing Order for the 
Distribution or Dispensing of Naloxone or Other Opioid Antagonists according to LA Rev Stat § 
40:978.283 or any other applicable statute.
Recommendation: Establish a Leave Behind Naloxone Program
Criminal justice agencies should collaborate with public health and community organizations to 
establish a naloxone leave behind program for first responders. At sites of overdose survival, 
first responders should be prepared to leave naloxone with the survivor of an overdose or 
individuals in a position to assist the survivor, as well as provide training on proper naloxone 
administration. This is recommended if it is allowable by the State of Louisiana’s Standing Order 
for the Distribution or Dispensing of Naloxone or Other Opioid Antagonists according to LA Rev 
Stat § 40:978.283 or any other applicable statute.
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Recommendation: Provide Insight Regarding Overdose Hotspots
Criminal justice agencies should partner with public health officials to share relevant data 
about the location of overdoses and the concentration of hotspots to inform the deployment of 
resources (e.g., Louisiana State Opioid Response Medication-Assisted Treatment Mobile Unit) 
and prevention specialists.
Recommendation: Implement a Public Health and Safety Team (PHAST)
Criminal justice agencies should partner with public health and community organizations to 
implement a Public Health and Safety Team (PHAST) responsible for conducting overdose 
fatality reviews. This practice will enable better coordination and development of strategies to 
allocate resources and services to prevent future overdoses.
Recommendation: Strengthen Community Partnerships to Expand 
Access Points
Criminal justice agencies should partner with public health and community organizations to 
implement protocols which support prevention efforts, community-based treatment, harm 
reduction, and recovery efforts. As first responders, criminal justice practitioners should 
emphasize connecting individuals with substance use disorders to viable treatment programs, 
removing existing barriers to adequate treatment and recovery, and reserving incarceration 
as a last resort. Furthermore, criminal justice agencies should join community-based treatment 
providers, advocating for adequate resources required to meet treatment demands. 
Recommendation: Expand Prescription Medication Disposal Programs
Criminal justice agencies should engage in community partnerships to expand prescription 
medication disposal programs by permanently establishing secure disposal sites for unused and 
expired medication at law enforcement substations and other amenable community locations. 
By expanding administrative disposal protocols and participating in community events to raise 
awareness of proper prescription medication disposal, criminal justice agencies can reduce 
prescription opioid abuse within local communities.
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Recommendation: Expand Community Education Efforts
IPS partners should expand planned community education efforts, such as push cards and 
community forums, to include information about situation-specific support programs for 
survivors (e.g., pregnancy-based treatment, neonatal treatment, safe needle exchange sites). 
Information about Medicaid and other public assistance treatment opportunities should be 
readily available.  
Recommendation: Support the Expansion of Treatment and 
Harm Reduction Efforts
IPS partners should support effective harm reduction efforts, such as needle exchange 
programs, Take Home Naloxone programs for hospitals, fentanyl testing kits, as well as 
community-wide access to evidence-based treatments such as MAT and peer-recovery 
programs. 
Recommendation: Publicize the Good Samaritan Laws
Criminal justice agencies should partner with public health and community organizations to 
raise public awareness of the current Good Samaritan laws, including situational limitations for 
immunity.
Recommendation: Bolster Prevention Efforts
The IPS inter-agency partners, communities, schools, and public health agencies should 
develop cross sector partnerships to prevent the development of substance misuse among 
youth and other vulnerable populations. Prevention efforts among partners should be 
highlighted in public awareness and educational campaigns. 
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IPS Partner Agencies
Baton Rouge Police Department
Drug Enforcement Administration
East Baton Rouge Parish Coroner’s Office
East Baton Rouge Parish District Attorney’s Office
East Baton Rouge Parish District Attorney’s Office - Crime Strategies Unit
East Baton Rouge Parish Emergency Medical Services 
East Baton Rouge Sheriff’s Office
Louisiana Board of Pharmacy - Prescription Monitoring Board
Louisiana Department of Corrections - Probation/Parole
Louisiana State University
US Attorney’s Office
US Postal Inspector
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